187 related articles for article (PubMed ID: 12694256)
1. Cytokine imbalance in hyper-IgE syndrome: reduced expression of transforming growth factor beta and interferon gamma genes in circulating activated T cells.
Ohga S; Nomura A; Ihara K; Takahata Y; Suga N; Akeda H; Shibata R; Okamura J; Kinukawa N; Hara T
Br J Haematol; 2003 Apr; 121(2):324-31. PubMed ID: 12694256
[TBL] [Abstract][Full Text] [Related]
2. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
[TBL] [Abstract][Full Text] [Related]
3. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
4. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
[TBL] [Abstract][Full Text] [Related]
5. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
6. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.
Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS
Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717
[TBL] [Abstract][Full Text] [Related]
8. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
9. Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease.
Horváth R; Rožková D; Lašťovička J; Poloučková A; Sedláček P; Sedivá A; Spíšek R
Clin Exp Immunol; 2011 Oct; 166(1):26-33. PubMed ID: 21910722
[TBL] [Abstract][Full Text] [Related]
10. Serum IgE level is negatively correlated with the ability of peripheral mononuclear cells to produce interferon gamma (IFNgamma): evidence of reduced expression of IFNgamma mRNA in atopic patients.
Teramoto T; Fukao T; Tashita H; Inoue R; Kaneko H; Takemura M; Kondo N
Clin Exp Allergy; 1998 Jan; 28(1):74-82. PubMed ID: 9537784
[TBL] [Abstract][Full Text] [Related]
11. Increased type 2 cytokine expression by both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells in blood circulation is associated with high serum IgE but not with atopic dermatitis.
Sato A; Tsuji K; Yamamura M; Morita Y; Kanzaki H; Tada J; Makino H; Arata J
J Invest Dermatol; 1998 Dec; 111(6):1079-84. PubMed ID: 9856820
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of interleukin-13 but not interleukin-4 in CD4+ cells from patients with the hyper-IgE syndrome.
Gudmundsson KO; Sigurjonsson OE; Gudmundsson S; Goldblatt D; Weemaes CM; Haraldsson A
Clin Exp Immunol; 2002 Jun; 128(3):532-7. PubMed ID: 12067309
[TBL] [Abstract][Full Text] [Related]
13. Chronic granulomatous disease with markedly elevated IgE levels mimicking hyperimmunoglobulin E syndrome.
Patiroglu T; Gungor HE; Lazaroski S; Unal E
Acta Microbiol Immunol Hung; 2013 Jun; 60(2):155-62. PubMed ID: 23827747
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin gene-related peptide modulates interleukin-13 in circulating cutaneous lymphocyte-associated antigen-positive T cells in patients with atopic dermatitis.
Antúnez C; Torres MJ; López S; Rodriguez-Pena R; Blanca M; Mayorga C; Santamaría-Babi LF
Br J Dermatol; 2009 Sep; 161(3):547-53. PubMed ID: 19566660
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
[TBL] [Abstract][Full Text] [Related]
16. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
[TBL] [Abstract][Full Text] [Related]
17. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
18. No indication for a defect in toll-like receptor signaling in patients with hyper-IgE syndrome.
Renner ED; Pawlita I; Hoffmann F; Hornung V; Hartl D; Albert M; Jansson A; Endres S; Hartmann G; Belohradsky BH; Rothenfusser S
J Clin Immunol; 2005 Jul; 25(4):321-8. PubMed ID: 16133988
[TBL] [Abstract][Full Text] [Related]
19. Undetectable interferon-alpha serum levels in a patient with atopic dermatitis.
Dolen JG; Mathur A
J Interferon Cytokine Res; 1995 Nov; 15(11):973-5. PubMed ID: 8590309
[TBL] [Abstract][Full Text] [Related]
20. T-helper 1, T-helper 2 and immunosuppressive cytokines in canine atopic dermatitis.
Nuttall TJ; Knight PA; McAleese SM; Lamb JR; Hill PB
Vet Immunol Immunopathol; 2002 Sep; 87(3-4):379-84. PubMed ID: 12072261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
